Microbot Medical, Inc.

$MBOT is leading the Prism MarketView MedDevices index today. The company announced it hopes to conduct a pivotal human clinical trial for its LIBERTY Endovascular Robotic Surgical System, after it successfully completed its pre-clinical study for the device

Share This Article

 

About the Author

Microbot Medical, Inc.

Joey Ramson